Diversify Advisory Services LLC Purchases Shares of 24,242 The Cooper Companies, Inc. $COO

Diversify Advisory Services LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 24,242 shares of the medical device company’s stock, valued at approximately $1,704,000.

Other hedge funds have also recently modified their holdings of the company. Wealthfront Advisers LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $605,000. Figure 8 Investment Strategies LLC purchased a new position in shares of Cooper Companies during the 2nd quarter valued at approximately $626,000. Citizens Financial Group Inc. RI acquired a new position in shares of Cooper Companies in the 2nd quarter valued at $747,000. BlackRock Inc. purchased a new stake in Cooper Companies during the second quarter worth $1,077,762,000. Finally, Pallas Capital Advisors LLC acquired a new stake in Cooper Companies during the second quarter valued at $557,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 1.3%

COO stock opened at $76.73 on Thursday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The business’s 50-day moving average is $71.59 and its 200 day moving average is $71.16. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The stock has a market cap of $14.96 billion, a price-to-earnings ratio of 65.03, a PEG ratio of 1.98 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter last year, the business posted $0.96 earnings per share. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of a number of analyst reports. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Stifel Nicolaus reduced their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. JPMorgan Chase & Co. lowered their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. UBS Group initiated coverage on Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, BNP Paribas Exane decreased their target price on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.